Back to search
Middle Cerebral Artery Infarction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Middle Cerebral Artery Infarction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Middle Cerebral Artery Infarction trials you may qualify forThe main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
The CMOSS-2 trial is a government-funded, prospective, multicenter, randomized controlled trial. It will recruit symptomatic chronic occlusion of the middle cer…
A multicenter, prospective, open-label, blinded-endpoint, randomized controlled trial to assess the effectiveness and safety of catheter-based focal intracrania…
In adult patients presenting to emergency departments within 24 hours of symptom onset with suspected acute stroke, we aim: 1. to identify early brain- and pat…
The purpose of this study is to investigate the safety and efficacy of endovascular treatment with or without preceding intravenous Tenecteplase in patients wit…
The mortality of malignant middle cerebral artery infarction (mMCAI) is up to 80%, while current available treatment is limited. The purpose of this study is to…